Characteristics of study participants (n=30)
| Characteristic | No of participants (%) |
| Age, years | |
| <45 | 4 (13) |
| 45–54 | 10 (33) |
| 55–64 | 7 (23) |
| 65–75 | 8 (27) |
| ≥75 | 1 (3) |
| Female gender | 16 (53) |
| Education | |
| Primary | 7 (23) |
| Secondary | 12 (40) |
| Tertiary | 11 (37) |
| Type of cancer | |
| Blood, blood-building organ | 13 (43) |
| Breast | 5 (17) |
| Colon/rectum | 4 (13) |
| Pancreas | 3 (10) |
| Prostate | 3 (10) |
| Other | 2 (7) |
| Months since cancer diagnosis | |
| <6 | 10 (33) |
| 7–12 | 6 (20) |
| 13–24 | 4 (13) |
| ≥36 | 10 (33) |
| Antineoplastic medication | |
| Chemotherapy | 25 (83) |
| Antibody/immunotherapy | 3 (10) |
| Combination | 2 (7) |
| Application of therapy | |
| Infusion | 25 (83) |
| Oral | 2 (7) |
| Combination (oral/intravenous) | 3 (10) |